CoreWeave specializes in providing flexible compute services tailored for the CGI and machine learning industries. The company offers a specialized cloud infrastructure platform that delivers GPU-accelerated computing resources, enabling clients to enhance their workflows and efficiently handle complex models. With a robust hardware and systems management infrastructure, CoreWeave supports clients in scaling operations and adapting to changing compute demands while maintaining competitive pricing.
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.
Private Equity Round in 2022
PosiGen CT, LLC sells and leases solar power systems, solar hot water systems, and energy efficiency upgrade solutions for residential and commercial users in Louisiana, New York, Connecticut, and Florida. It offers solar panel systems for heating, cooling, and illuminating homes and offices. The company also provides solar energy; energy efficiency audit services; and assess and permit, panel installation, and inspection services. The company was founded in 2011 and is based in Jefferson, Louisiana with additional offices in New York and Connecticut.
ViRB is a technology-enabled company that source, train, and deploy new clinical research professionals into the life sciences industry. The company was founded in 2021 and is based in Brookline, Massachusetts, United States.
Private Equity Round in 2021
CoreWeave specializes in providing flexible compute services tailored for the CGI and machine learning industries. The company offers a specialized cloud infrastructure platform that delivers GPU-accelerated computing resources, enabling clients to enhance their workflows and efficiently handle complex models. With a robust hardware and systems management infrastructure, CoreWeave supports clients in scaling operations and adapting to changing compute demands while maintaining competitive pricing.
Comtech Telecommunications Corp. designs, develops, produces and markets innovative products, systems and services for advanced communications solutions. Comtech has grown substantially in recent years. They believe they are well positioned for growth.
Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics, and machine learning to enhance a surgeon’s intra-operative decision making, and reduce unintended and preventable surgical complications. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Benson Hill is an agricultural technology company focused on crop improvement, particularly in soy protein innovation. By leveraging its proprietary CropOS™ platform, the company integrates machine learning, genomic data, and traditional breeding techniques to streamline the development of healthier and more sustainable food products. Benson Hill emphasizes unlocking the natural genetic diversity of plants to empower innovators in creating flavorful and nutritious ingredients. The company operates a Crop Accelerator for rapid prototyping and is developing a diverse seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. Its revenue is generated from both proprietary and non-proprietary product categories, reflecting its commitment to advancing agricultural innovation.
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.
It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Evolv Technology specializes in noninvasive body scanners designed for touchless security screening, focusing on enhancing safety in public spaces. The company offers a range of products, including Evolv Express for firearm and bomb detection, Evolv Edge for checkpoint security, and Evolv Pinpoint for facial recognition. These systems are utilized in various settings, such as schools, stadiums, hospitals, and entertainment venues, to ensure the safety of employees, visitors, and VIPs. Founded in 2013 and headquartered in Waltham, Massachusetts, Evolv Technology aims to improve security protocols by integrating advanced sensors and artificial intelligence, enabling reliable scanning without compromising the visitor experience. The company has screened over 50 million individuals, successfully preventing more than 5,000 weapons from entering secure areas. With a leadership team comprising veterans from security agencies, Evolv is committed to providing effective solutions for both government and private sectors.
OncoResponse Inc. is an immuno-oncology company based in Houston, Texas, focused on discovering new cancer immunotherapies and therapeutic antibodies. The company collaborates with MD Anderson Cancer Center to utilize the I-STAR™ platform, which analyzes the human memory B-cell repertoire of patients who have demonstrated exceptional responses to immunotherapy, referred to as "Elite Responders." By studying these patients, OncoResponse aims to harness the human immune system to identify fully human monoclonal antibodies and novel targets. This approach is intended to facilitate the development of innovative antibody-derived therapeutics for cancer treatment.
Judo Bank Pty. Ltd., founded in 2016 and based in Southbank, Australia, specializes in providing lending services to small and medium enterprises (SMEs). The bank offers a range of financial products, including business loans, lines of credit, equipment loans, and finance leases. Recognizing the vital role SMEs play in the Australian economy, Judo Bank aims to deliver practical banking solutions tailored to the unique needs of these businesses. By prioritizing customer relationships, Judo Bank ensures direct interaction with decision-makers who assess each loan application based on its individual merits. This approach contrasts with traditional banking practices that often rely on complex processes. Judo Bank’s commitment to understanding its clients' specific circumstances enables it to offer customized financial solutions, fostering a supportive environment for SMEs that often lack adequate banking support.
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers that lack effective treatments. The company's lead product, IGV-001, is an autologous tumor cell vaccine designed to stimulate a robust immune response against tumor cells by utilizing the patient's own immune system. Imvax employs advanced methodologies, including patient cell harvest, treatment, and implants, as well as techniques that promote immunogenic cell death and activate both the innate and adaptive immune responses. Founded in 2015 by a team of experienced professionals, Imvax aims to address significant unmet medical needs in oncology through its novel therapeutic approaches.
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers that lack effective treatments. The company's lead product, IGV-001, is an autologous tumor cell vaccine designed to stimulate a robust immune response against tumor cells by utilizing the patient's own immune system. Imvax employs advanced methodologies, including patient cell harvest, treatment, and implants, as well as techniques that promote immunogenic cell death and activate both the innate and adaptive immune responses. Founded in 2015 by a team of experienced professionals, Imvax aims to address significant unmet medical needs in oncology through its novel therapeutic approaches.
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
Private Equity Round in 2017
LUCID ENERGY GROUP is a midstream services company providing gathering, treating, processing, compression and transportation services to producers working in the Permian Basin. LUCID has developed and is continuing to expand its greenfield gathering and processing facilities in the high-growth production areas of the Wolfcamp and Clines shales. LUCID was formed in 2011 with equity commitments from EnCap Flatrock Midstream of San Antonio.
Headquartered in Dallas, LUCID is focusing its operations on the Eastern Shelf region of the Permian Basin and has field offices near its operating assets in Sterling City and San Angelo. The company's ability to create unique solutions distinguishes LUCID and puts the company in a strong position to meet the accelerating demand for midstream infrastructure in the region.
At LUCID, they understand how important service is to our customers. They hold fast to their vision and creativity. They believe in communicating clearly so that every deal is easily understood. They are perceptive and in the moment with our customers while we work hard to develop unconventional solutions and partner with them for success. Their customers trust them because there are no surprises. At LUCID, they are Vision At Work.
A key way for owners of small and midsized businesses to truly be successful and increase their net worth is to own their commercial real estate. Most people think that the dream of commercial property ownership is difficult and expensive, with large down payments and high, variable interest rates. With cash being such an important asset for any company, many business owners cannot afford to spend so much of their hard-earned capital to purchase their commercial property, even though they know what a great long-term investment owning their own property will be.
SurgRx, Inc is a developer of laparoscopic vessel fusion tools for surgical hemostasis. The company develops tissue sealing and hemostasis systems for laparoscopic and open surgery. It also offers EnSeal, a tissue sealing and hemostasis system that allows surgeons to seal and transect vessels, pedicles, and tissue bundles to achieve surgical hemostasis. SurgRx, Inc is based in Redwood City, California.
Kintera is leader and pioneering provider of Software as a Service (SaaS) solutions to the nonprofit and government sectors. They are a leading provider of software that enables nonprofit organizations to use the Internet to bring their employees, volunteers and donors together in online, interactive communities that increase donations, reduce fundraising costs and build affinity for an organization's cause.